-- but Glaxo contends that Cipla violates the companies' patents and international intellectual- property agreements"(Boseley, 2002). In moral defense of its actions, Glaxo's CEO, told shareholders "Some people might see patents as the obstacle to g Continue Reading...
Recent reports released by UNAIDS has confirmed the fact that Nevirapine treatment is still beyond the reach for 90% of HIV infected pregnant women. [Elizabeth Glacier Pediatric AIDS Foundation] Government Initiative It goes without saying that th Continue Reading...
He says that if the prices are still too high, the UN should offer subsidies. (Boseley, 2003) 2. Rupert Bondy - Senior Vice President and General Counsel He played a key role in the merger between Glaxo Welcome and SmithKline as well as after the Continue Reading...
As a result, this protection was removed to increase the supply and ensure that the public has access to affordable drugs. ("Pharmaceutical Companies," n.d., pp. 97-99) Some of the negative implications of this decision are that there could be larg Continue Reading...
Japanese-American Biopharmaceutical Industry in the 21st Century Optimizing Ethical Drug Availability Between These Two Pharmaceutical Superpowers" The Japanese-American biopharmaceutical industry represents an ongoing international effort betwee Continue Reading...
Again, Mc Donald's has managed to deal with competitive threats posed by both these market players due to the fact that the prices that Burger King, Starbucks and Costa Coffee charge are much higher than that charged by Mc Donald's. The primary reas Continue Reading...
